-

Xevant Announces New E-Book: Navigating Obesity Care and GLP-1 Coverage: A Guide for Employers

LEHI, Utah--(BUSINESS WIRE)--As obesity rates in the United States have reached 41.9 percent among adults, Xevant has released a new e-book, Navigating Obesity Care and GLP-1 Coverage: A Guide for Employers, designed to empower employers with the tools and insights needed to address this critical health and economic challenge. The e-book offers actionable guidance on crafting effective, sustainable corporate weight management programs that drive meaningful results for both employees and employers.

A Resource for Employers and Consultants

Employers are increasingly grappling with the challenge of balancing rising healthcare costs and employee demands for effective weight loss treatments like GLP-1 medications. With healthcare costs tied to obesity exceeding $260 billion annually, many organizations are caught between budget constraints and the need to provide meaningful support for employee health and wellness. Navigating insurance coverage for high-demand solutions, such as GLP-1s, while ensuring long-term cost containment and employee satisfaction, requires strategic planning—an area where this e-book provides critical insights and practical guidance.

What’s Inside the E-Book:

"Obesity isn't just a personal health issue—it’s a corporate challenge impacting healthcare costs, productivity, and employee well-being," said Jason Hardin, Chief Revenue Officer at Xevant. "Our e-book equips employers with the knowledge and strategies needed to implement cost-effective weight management solutions that improve employee health outcomes and reduce long-term healthcare expenses." Employers will find in-depth coverage of the following topics:

  • The Weight of Obesity: Understanding its prevalence and economic impact.
  • Achieving Long-Term Weight Loss Success: Combining lifestyle changes with medications like GLP-1s.
  • The Case for Coverage: Exploring how GLP-1 coverage benefits outweigh costs.
  • Building Sustainable Corporate Weight Management Programs: Essential components for success.
  • Implementing Tailored Solutions: Meeting organizational goals effectively with a solution tailored specifically for employers.

Innovative and Sustainable Solutions

Navigating Obesity Care and GLP-1 Coverage: A Guide for Employers highlights the importance of holistic approaches, cost control measures, personalized care, and flexible program designs. With tools like real-time program insights and tailored clinical guidance, employers can proactively support their employees’ health while managing costs effectively.

Unlike traditional resources, this e-book helps employers navigate the complexities of GLP-1 coverage while supporting employees through their GLP-1 journey. Employers can gain clarity on how to balance immediate costs with long-term benefits, ensuring a win-win scenario for both employees and the organization.

Get Your Copy Today

To learn more about implementing sustainable weight loss programs and overcoming the challenges of obesity care, download the e-book and connect with an expert at Xevant today.

About Xevant

Xevant is a leader in healthcare solutions, providing innovative tools and insights that enable employers to achieve better health outcomes and cost efficiencies. Through a unique partnership with telehealth leader, Ivím Health, Xevant is committed to helping employers address today’s most pressing health challenges with confidence and clarity.

More News From Xevant

Xevant Unveils 2025 Drug Price Inflation White Paper: A Data-Driven Look at Rising Pharmaceutical Costs and Future Implications

LEHI, Utah--(BUSINESS WIRE)--Xevant, a leading provider of real-time data analytics for pharmacy benefit management, today announced the release of its 2025 Drug Price Inflation White Paper, providing key insights into the ongoing surge in pharmaceutical prices and what it means for payers, employers, and pharmacy benefit managers (PBMs). As the cost of healthcare continues to escalate, the new year has brought a fresh wave of price hikes across the pharmaceutical landscape. Within the first tw...

Xevant Introduces the All-New Biosimilar Dashboard, A Real-Time Analytics Tool to Accelerate Biosimilar Adoption and Reduce Unnecessary Biologic Drug Spend

LEHI, Utah--(BUSINESS WIRE)--Xevant, a leader in pharmacy benefits automation, today announces the launch of its all-new Biosimilar Dashboard, a real-time analytics tool designed to streamline biosimilar adoption and reduce unnecessary spending on biologic drugs. The Biosimilar Dashboard empowers health plans, employers, pharmacy benefit managers (PBMs), consultants, and benefits advisors by transforming fragmented prescription data into timely, actionable insights. This enhanced visibility ena...

Xevant Enhances Automated Analytics Platform with AI to Revolutionize Healthcare Data Ingestion and Standardization

LEHI, Utah--(BUSINESS WIRE)--Xevant, a leader in automated analytics for the pharmacy benefits industry, today announced the launch of new AI-powered capabilities designed to revolutionize the ingestion and standardization of healthcare data. These advancements address one of the most significant challenges faced by pharmacy benefit managers (PBMs), health plans, consultants, and employers—managing the influx of diverse, complex data formats quickly and efficiently. Key Features: Xevant’s new A...
Back to Newsroom